The SGC is a public-private partnership that supports the discovery of new medicines through open access research.
Welcome to SGC
OOMMPPAA: A Tool To Aid Directed Synthesis by the Combined Analysis of Activity and Structural Data.
J Chem Inf Model
Acta Crystallogr D Biol Crystallogr
Trends Biochem Sci
Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
J Med Chem
Proc Natl Acad Sci U S A
SGC-CHDI patent-free partnership selected as an 'Innovator' presenter at 'Partnering for Cures' meeting in New York, November 16-18, 2014.
Posted on 29th October 2014
Posted on 28th October 2014